PolyPid Revenue
Pharmaceutical Manufacturing • 
Petah Tikva, Center District, Israel • 51-100 Employees
PolyPid revenue & valuation
| Annual revenue | $5,561,075 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $17,800,000 |
| Total funding | $80,500,000 |
Key Contacts at PolyPid
Jacob Harel
Chairman Of The Board Of Directors
Dalit Hazan
Deputy Chief Executive Officer
Shmuel Sharoni
Medical Director
Tzvia Selzer
Director Of Intellectual Property
Amir Weisberg
Ceo
Jacob Harel
Chair Of The Board Of Directors
Company overview
| Headquarters | Petah Tikva, Center District, Israel |
| Phone number | +972747195700 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Employees | 51-100 |
| Socials |
PolyPid Email Formats
PolyPid uses 5 email formats. The most common is {first name}.{last name} (e.g., john.doe@polypid.com), used 52.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@polypid.com | 56.8% |
{first initial}.{last name} | j.doe@polypid.com | 35.3% |
{first initial} | j@polypid.com | 5.9% |
{first initial}{last name} | jdoe@polypid.com | 2% |
About PolyPid
We are a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. Our PLEX (Polymer-Lipid Encapsulation matriX) technology is a unique platform that is anchored in the surgical site to provide controlled and continuous delivery of medications. Our product candidates are designed to deliver medications in the body over days to several months in a controlled manner. This allows surgeons to deliver medication right to the surgical site to improve patient outcomes in localized medical conditions such as; infection, pain, inflammation and cancer. Our initial infection treatment targets are Surgical Site Infections (SSIs), the second most prevalent type of Healthcare Acquired Infections (HAIs). SSIs have substantial negative impact on patients’ clinical outcomes and also pose a significant healthcare system burden. We strive to reduce overall surgical infection rates, including infections due to antibiotic-resistant bacteria which the FDA defined as being one of the world’s most pressing public health problems. NASDAQ: PYPD
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
PolyPid has 36 employees across 11 departments.
Departments
Number of employees
Funding Data
Explore PolyPid's funding history, including investment rounds, total capital raised, and key backers.
PolyPid Tech Stack
Discover the technologies and tools that power PolyPid's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Page builders
Photo galleries
JavaScript libraries
Web servers
Font scripts
JavaScript libraries
WordPress plugins
Programming languages
Blogs
UI frameworks
Canada
Denmark
Frequently asked questions
4.8
40,000 users
